Human IkBa (20-39) is a peptide segment modeling the regulatory region involved in NF-κB inhibitor interactions. Its sequence supports analysis of helix propensity and phosphorylation-site positioning. Researchers examine its conformational ensemble for insights into docking surfaces. The molecule contributes to intracellular signaling research.
CAT No: S06032
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
4. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
5. Cell-based adhesion assays for isolation of snake venom’s integrin antagonists
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.